San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, AseptiScope is raising $8,735,616.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Scott Mader played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AseptiScope

AseptiScope Inc., is a privately funded San Diego based company founded in 2016 and led by clinical innovation experts, leading medical researchers, and practicing physicians. The company’s leadership includes a seasoned team with a successful track record of working together to deliver blockbuster product introductions of clinically proven therapeutics and technologies. We provide Infection Protection for Clinician & Patient with novel aseptic solutions. If you are a clinician, we are dedicated to making infection control fast and simple. If you are a patient, we are here to protect you. We are driven to bring innovative and validated solutions that lower the risk of contamination and infection in healthcare systems.

To learn more about AseptiScope, visit http://aseptiscope.com/

Contact:
Scott Mader, Chief Executive Officer
844-980-2998
https://www.linkedin.com/in/scott-mader-594177/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved